Donanemab

2 条新闻

来自世界各地可信来源的关于 Donanemab 的最新新闻和动态。

FDA gives accelerated approval to Eli Lilly's Alzheimer's drug donanemab

The U.S. Food and Drug Administration has granted accelerated approval to donanemab, an Eli Lilly monoclonal antibody for early-stage Alzheimer's disease. The decision gives patients and doctors…

0 1hr前

FDA approves donanemab, first new Alzheimer’s drug in nearly two years

The U.S. Food and Drug Administration has approved donanemab, a treatment for people in the early stages of symptomatic Alzheimer’s disease. The decision ends a long wait for a new option in a field…

3hr前

0 3hr前